Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:
• Patients less than 18 years old
• Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases.
Locations
Other Locations
Taiwan
Chang Gung Memorial Hospital
RECRUITING
Taoyuan District
Contact Information
Primary
Wei-Chi Wu, MD, PhD
weichi666@gmail.com
886975365848
Time Frame
Start Date: 2024-03-05
Estimated Completion Date: 2028-02-28
Participants
Target number of participants: 60
Treatments
Experimental: Short vitrector group
All enrolled patients will receive vitrectomy with the 18 mm short vitrectomy probe (25+ Short TOTALPLUS Vit Pak, 7500 CPM, Str Endoillum. w/ RFID, Alcon Laboratories Inc., Fort Worth, TX, USA.) for various vitreoretinopathies.
Related Therapeutic Areas
Sponsors
Leads: Chang Gung Memorial Hospital